A detailed history of Vestal Point Capital, LP transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 4,000,000 shares of KALV stock, worth $35 Million. This represents 3.51% of its overall portfolio holdings.

Number of Shares
4,000,000
Previous 2,300,000 73.91%
Holding current value
$35 Million
Previous $27.1 Billion 70.96%
% of portfolio
3.51%
Previous 2.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$9.46 - $15.39 $16.1 Million - $26.2 Million
1,700,000 Added 73.91%
4,000,000 $46.3 Billion
Q2 2024

Aug 14, 2024

BUY
$10.35 - $12.49 $17 Million - $20.5 Million
1,645,000 Added 251.15%
2,300,000 $27.1 Billion
Q1 2024

May 13, 2024

BUY
$11.07 - $16.04 $7.25 Million - $10.5 Million
655,000 New
655,000 $7.77 Billion

Others Institutions Holding KALV

About KalVista Pharmaceuticals, Inc.


  • Ticker KALV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,602,000
  • Market Cap $216M
  • Description
  • KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...
More about KALV
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.